0001415889-23-004192.txt : 20230303 0001415889-23-004192.hdr.sgml : 20230303 20230303180020 ACCESSION NUMBER: 0001415889-23-004192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOYES TIMOTHY P CENTRAL INDEX KEY: 0001185035 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 23706365 MAIL ADDRESS: STREET 1: 1365 MAIN STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-03032023_060301.xml X0306 4 2023-03-01 0001798749 Aerovate Therapeutics, Inc. AVTE 0001185035 NOYES TIMOTHY P C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2023-03-01 4 M 0 15000 2.14 A 15000 D Common Stock 2023-03-01 4 S 0 5962 22.7071 D 9038 D Common Stock 2023-03-01 4 S 0 2672 23.8109 D 6366 D Common Stock 2023-03-01 4 S 0 5316 24.6878 D 1050 D Common Stock 2023-03-01 4 S 0 1050 25.67 D 0 D Stock Option (Right to Buy) 2.14 2023-03-01 4 M 0 15000 0 D 2031-04-01 Common Stock 15000 433381 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.25 to $23.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.31 to $24.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.33 to $25.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter. /s/ George A. Eldridge, Attorney-in-Fact 2023-03-03